Table 2.

Immunization scheme and n = biological independent samples analyzed in the assays indicated

1st vaccination		ChAd	ChAd	ChAd	ChAd	ChAd	ChAd	ChAd	ChAd	ChAd	ChAd	BNT	BNT	BNT	BNT	BNT
2nd vaccination		-----	ChAd	ChAd	ChAd	ChAd	-----	BNT	BNT	BNT	BNT	-----	BNT	BNT	BNT	BNT
3rd vaccination		-----	-----	-----	-----	BNT	-----	-----	-----	-----	BNT	-----	-----	-----	-----	BNT
Time after last vaccination		2 mo	14d	4 mo	6mo	14d	2 mo	14d	4 mo	6mo	14d	21d	1mo	7 mo	9 mo	21d
Anti-S1-IgG	Fig. 1b, c	41	39	37	26	29	80	80	73	61	61	37	38	49	14	24
Spike-specific B cells	Fig. 1d	41	35	32	25	28	83	74	68	59	61	n.d.	n.d.	n.d.	n.d.	n.d.
sVNT Wuhan	Fig. 2a, Suppl. Fig. 5a	40	39	37	26	27	82	79	73	60	59	34	47	33	48	24
sVNT Alpha	Fig. 2b, Suppl. Fig. 5b	40	39	37	26	27	82	79	73	60	59	34	47	33	48	24
sVNT Beta	Fig. 2b, Suppl. Fig. 5b	40	39	37	26	27	82	79	73	60	59	34	47	33	48	24
sVNT Gamma	Fig. 2b, Suppl. Fig. 5b	40	39	37	26	27	82	79	73	60	59	34	47	33	48	24
sVNT Delta	Fig. 2a, Suppl. Fig. 5a	40	39	37	26	27	82	79	73	60	59	34	47	33	48	24
sVNT Omicron	Fig. 2a, Suppl. Fig. 5a	n.d.	39	n.d.	26	27	n.d.	79	n.d.	60	59	n.d.	44	n.d.	48	24
Spike-specific CD4 cells	Fig. 3a, Suppl. Fig. 7	41	35	32	25	28	82	74	68	59	61	n.d.	n.d.	n.d.	n.d.	n.d.
Spike-specific CD8 cells	Fig. 3b, Suppl. Fig. 7	41	34	32	25	28	82	67	68	59	63	n.d.	n.d.	n.d.	n.d.	n.d.
IGRA	Fig. 3c	27	24	20	24	16	60	53	42	56	43	n.d.	n.d.	n.d.	n.d.	n.d.

n.d not determined.